These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31011340)

  • 21. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system.
    Tagami T; Ernsting MJ; Li SD
    J Control Release; 2011 Sep; 154(3):290-7. PubMed ID: 21640149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
    Stevens PJ; Lee RJ
    Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a bone-targeted pH-sensitive liposomal formulation containing doxorubicin: physicochemical characterization, cytotoxicity, and biodistribution evaluation in a mouse model of bone metastasis.
    Ferreira Ddos S; Faria SD; Lopes SC; Teixeira CS; Malachias A; Magalhães-Paniago R; de Souza Filho JD; Oliveira BL; Guimarães AR; Caravan P; Ferreira LA; Alves RJ; Oliveira MC
    Int J Nanomedicine; 2016; 11():3737-51. PubMed ID: 27563241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro cytotoxicity of Stealth liposomes co-encapsulating doxorubicin and verapamil on doxorubicin-resistant tumor cells.
    Wang J; Goh B; Lu W; Zhang Q; Chang A; Liu XY; Tan TM; Lee H
    Biol Pharm Bull; 2005 May; 28(5):822-8. PubMed ID: 15863886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
    J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and ocular pharmacokinetics of hyaluronan acid-modified mucoadhesive liposomes.
    Lin J; Wu H; Wang Y; Lin J; Chen Q; Zhu X
    Drug Deliv; 2016 May; 23(4):1144-51. PubMed ID: 25533876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of drug release from liposomal formulations in ocular fluid.
    Jafari MR; Jones AB; Hikal AH; Williamson JS; Wyandt CM
    Drug Deliv; 1998; 5(4):227-38. PubMed ID: 19569989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs.
    Gabizon AA; Barenholz Y; Bialer M
    Pharm Res; 1993 May; 10(5):703-8. PubMed ID: 8321835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased intracellular drug accumulation and complete chemosensitization achieved in multidrug-resistant solid tumors by co-administering valspodar (PSC 833) with sterically stabilized liposomal doxorubicin.
    Krishna R; St-Louis M; Mayer LD
    Int J Cancer; 2000 Jan; 85(1):131-41. PubMed ID: 10585596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release.
    Luo D; Carter KA; Razi A; Geng J; Shao S; Giraldo D; Sunar U; Ortega J; Lovell JF
    Biomaterials; 2016 Jan; 75():193-202. PubMed ID: 26513413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumor.
    Mayer LD; Bally MB; Cullis PR; Wilson SL; Emerman JT
    Cancer Lett; 1990 Sep; 53(2-3):183-90. PubMed ID: 2208078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
    Al Asmari AK; Ullah Z; Tariq M; Fatani A
    Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation.
    Begum MY; M Osmani RA; Alqahtani A; Ghazwani M; Hani U; Ather H; Atiya A; Rahamathulla M; Siddiqua A
    PLoS One; 2022; 17(4):e0264518. PubMed ID: 35472207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.
    Rahman A; Carmichael D; Harris M; Roh JK
    Cancer Res; 1986 May; 46(5):2295-9. PubMed ID: 3697976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EphA2 targeted doxorubicin stealth liposomes as a therapy system for choroidal neovascularization in rats.
    Wang JL; Liu YL; Li Y; Dai WB; Guo ZM; Wang ZH; Zhang Q
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7348-57. PubMed ID: 22977140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thioether Phosphatidylcholine Liposomes: A Novel ROS-Responsive Platform for Drug Delivery.
    Du Y; He W; Xia Q; Zhou W; Yao C; Li X
    ACS Appl Mater Interfaces; 2019 Oct; 11(41):37411-37420. PubMed ID: 31556583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).
    Parr MJ; Masin D; Cullis PR; Bally MB
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1319-27. PubMed ID: 9067319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biopharmaceutical evaluation of the liposomes prepared by rehydration of freeze-dried empty liposomes (FDELs) with an aqueous solution of a drug.
    Yachi K; Harashima H; Kikuchi H; Sudo R; Yamauchi H; Ebihara K; Matsuo H; Funato K; Kiwada H
    Biopharm Drug Dispos; 1996 Oct; 17(7):589-605. PubMed ID: 8894117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.